MCID: HPT070
MIFTS: 39

Hepatosplenic T-Cell Lymphoma malady

Categories: Cancer diseases, Blood diseases, Rare diseases, Immune diseases, Liver diseases

Aliases & Classifications for Hepatosplenic T-Cell Lymphoma

About this section
Sources:
30ICD10, 31ICD10 via Orphanet, 54Orphanet, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Hepatosplenic T-Cell Lymphoma:

Name: Hepatosplenic T-Cell Lymphoma 54 68

Characteristics:

Orphanet epidemiological data:

54
hepatosplenic t-cell lymphoma:
Age of onset: Adolescent,Adult

Classifications:



External Ids:

Orphanet54 ORPHA86882
UMLS via Orphanet69 C1333984
ICD10 via Orphanet31 C86.1
ICD1030 C86.1

Summaries for Hepatosplenic T-Cell Lymphoma

About this section
MalaCards based summary: Hepatosplenic T-Cell Lymphoma is related to lymphoma and crohn's disease. An important gene associated with Hepatosplenic T-Cell Lymphoma is CHN2 (Chimerin 2), and among its related pathways is Innate Lymphoid Cell Differentiation Pathways. Affiliated tissues include spleen, t cells and b cells.

Related Diseases for Hepatosplenic T-Cell Lymphoma

About this section

Diseases related to Hepatosplenic T-Cell Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)
idRelated DiseaseScoreTop Affiliating Genes
1lymphoma10.8
2crohn's disease10.3
3leukemia10.3
4inflammatory bowel disease10.2
5large granular lymphocyte leukemia10.1
6t-cell large granular lymphocyte leukemia10.1
7hematopoietic stem cell transplantation10.0
8hepatitis10.0
9thrombocytopenia10.0
10malignant glioma9.9GZMB, TIA1
11alström syndrome9.9GZMB, TIA1
12skeletal muscle cancer9.9GZMB, TIA1
13tibial adamantinoma9.9GZMB, TIA1
14superior limbic keratoconjunctivitis9.9GZMB, TIA1
15fibrosclerosis of breast9.9GZMB, TIA1
16multiple carboxylase deficiency9.9CD7, DPP4
17uterine ligament endometrioid adenocarcinoma9.9GZMB, TIA1
18congenital sucrase-isomaltase deficiency with starch and lactose intolerance9.9GZMB, TIA1
19linear lichen planus9.9GZMB, TIA1
20macrogyria, pseudobulbar palsy and mental retardation9.9GZMB, TIA1
21malignant teratoma9.9GZMB, TIA1
22cerebral lipidosis9.9GZMB, TIA1
23post-transplant lymphoproliferative disease9.9GZMB, TIA1
24childhood immature teratoma of ovary9.9GZMB, TIA1
25plasmodium ovale malaria9.9GZMB, TIA1
26mixed cell type cancer9.8GZMB, TIA1
27systemic lupus erythematosus9.8
28myelodysplastic syndrome9.8
29acute leukemia9.8
30autoimmune hepatitis9.8
31common variable immunodeficiency9.8
32hemolytic anemia9.8
33hepatitis b9.8
34myelofibrosis9.8
35sinusitis9.8
36schistosomiasis9.8
37purpura9.8
38progressive multifocal leukoencephalopathy9.8
39t-cell leukemia9.8
40myeloid leukemia9.8
41lupus erythematosus9.8
42ring chromosome 79.8
43lip cancer9.8GZMB, TIA1
44hyperaldosteronism, familial, type ii9.8GZMB, TIA1
45pre-malignant neoplasm9.8GZMB, TIA1
46coarctation of aorta9.7CD7, GZMB, TIA1
47aortic arch interruption9.7GZMB, TIA1
48collagen type iii glomerulopathy9.0ABCB1, CD7, CHN2, DPP4, GZMB, PPP1R9A

Graphical network of the top 20 diseases related to Hepatosplenic T-Cell Lymphoma:



Diseases related to hepatosplenic t-cell lymphoma

Symptoms & Phenotypes for Hepatosplenic T-Cell Lymphoma

About this section

Drugs & Therapeutics for Hepatosplenic T-Cell Lymphoma

About this section

Drugs for Hepatosplenic T-Cell Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 151)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
EtoposideapprovedPhase 4, Phase 2, Phase 1, Early Phase 1126933419-42-036462
Synonyms:
(-)-Etoposide
121471-01-0
136598-18-0
201594-04-9
33419-42-0
35317-32-9
4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside
4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside
51854-34-3
76576-58-4
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
AB00438905
AC1L1FN8
AC1L1VT3
AC1L6246
AC1NR4OG
AC1O4WGG
AC1O7M1N
AC1Q47JJ
Ambap33419-42-0
BPBio1_000673
BRD-K37798499-001-02-5
BSPBio_000611
Bio1_000489
Bio1_000978
Bio1_001467
C01576
CCRIS 2392
CHEBI:4911
CHEBI:588795
CHEMBL44657
CID11758093
CID284997
CID3310
CID36462
CID5284558
CID6419930
CID6610299
CPD000112002
D00125
DB00773
DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,
Demethyl Epipodophyllotoxin Ethylidine Glucoside
Demethyl-epiodophyllotoxin ethylidene glucoside
Demethylepipodophyllotoxin-beta-D-ethylideneglucoside
E0675
E1383_SIGMA
EINECS 251-509-1
EPE
EPEG
ETOP
Epipodophyllotoxin
Epipodophyllotoxin VP-16213
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
Eposide
Eposin
 
Eposin, Vepesid, VP-16, Toposar, Etoposide
Etopol
Etopophos
Etopophos (phosphate salt)
Etoposid
Etoposide
Etoposide (JP15/USP/INN)
Etoposide (VP16)
Etoposide [USAN:INN:BAN:JAN]
Etoposido
Etoposido [INN-Spanish]
Etoposidum
Etoposidum [INN-Latin]
Etosid
HMS1569O13
HMS2052N05
HMS2089F14
HSDB 6517
I06-0248
KBioSS_002410
LS-1214
Lastet
MLS000049957
MLS001074951
MLS001424283
MLS002153463
MLS002207239
MLS002222184
MolPort-003-983-431
MolPort-004-905-001
MolPort-004-955-161
NCGC00025056-02
NChemBio.2007.10-comp19
NK 171
NSC 141540
NSC-141540
NSC141540
Prestwick0_000396
Prestwick1_000396
Prestwick2_000396
Prestwick3_000396
Prestwick_211
S1225_Selleck
SAM001246880
SMR000112002
SPBio_002532
ST056353
Toposar
UNII-6PLQ3CP4P3
VP 16
VP 16 (pharmaceutical)
VP 16-213
VP 16213
VP-16
VP-16-213
VePESID (TN)
VePesid
Vepesid
Vepesid J
Vepeside
ZINC03830818
ZINC03938684
Zuyeyidal
etoposide
nchembio.573-comp8
nchembio873-comp2
trans-Etoposide
2
Cyclophosphamideapproved, investigationalPhase 4, Phase 2, Phase 1, Early Phase 1293550-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
3
Prednisoneapproved, vet_approvedPhase 4, Phase 2, Phase 1139853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
4
Vincristineapproved, investigationalPhase 4, Phase 2, Phase 19222068-78-2, 57-22-75978
Synonyms:
22-Oxovincaleukoblastin
22-Oxovincaleukoblastine
28379-27-3
57-22-7
AC1L1LJC
C07204
C46H56N4O10
CCRIS 5763
CHEBI:28445
CID5978
D08679
DB00541
EINECS 200-318-1
HMS2090E19
HSDB 3199
Indole alkaloid
LCR
LS-228
Leurocristine
Lilly 37231 (1:1 sulfate salt)
Liposomal Vincristine
Marqibo
NCGC00163700-01
NCI-C04864
NCI60_026703
NSC-67574
Onco TCS
 
Oncovin
Oncovin (1:1 sulfate salt)
Oncovine
Tecnocris
Tecnocris (TN)
UNII-5J49Q6B70F
VCR
VIN
Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine
Vincasar
Vincasar (1:1 sulfate salt)
Vincasar PFS
Vincrex
Vincrex (1:1 sulfate salt)
Vincristin
Vincristina
Vincristina [DCIT]
Vincristine (INN)
Vincristine Sulfate
Vincristine Sulfate PFS
Vincristine [INN:BAN]
Vincristinum
Vincristinum [INN-Latin]
Vincrstine
Vincrystine
Vinkristin
Z-D-Val-Lys(Z)-OH
vincristine
5
MethotrexateapprovedPhase 4, Phase 215511959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
6
InfliximabapprovedPhase 4392170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
7
IfosfamideapprovedPhase 4, Phase 14003778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide (JAN/USP/INN)
 
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
8
MechlorethamineapprovedPhase 4, Phase 2, Phase 139751-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
 
KBioGR_001448
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
β,β'-dichlorodiethyl-N-methylamine
9
Doxorubicinapproved, investigationalPhase 4, Phase 1, Phase 2175123214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
10
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 2, Phase 1439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
11
leucovorinapproved, NutraceuticalPhase 4, Phase 2, Phase 1323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
12
PirarubicininvestigationalPhase 42272496-41-4
Synonyms:
Adriamycin, tetrahydropyranyl
 
THP-Adm
THP-Doxorubicin
Theprubicin
13
DoxilApproved June 1999Phase 4, Phase 1, Phase 2175131703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
14HormonesPhase 4, Phase 2, Phase 114415
15Vitamin B ComplexPhase 4, Phase 2, Phase 14337
16Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 2, Phase 113168
17Topoisomerase InhibitorsPhase 4, Phase 2, Phase 1, Early Phase 15069
18Hormone AntagonistsPhase 4, Phase 2, Phase 113180
19Immunosuppressive AgentsPhase 4, Phase 2, Phase 1, Early Phase 113086
20Alkylating AgentsPhase 4, Phase 2, Phase 1, Early Phase 14827
21glucocorticoidsPhase 4, Phase 2, Phase 15103
22Antineoplastic Agents, HormonalPhase 4, Phase 2, Phase 15592
23Antirheumatic AgentsPhase 4, Phase 2, Phase 1, Early Phase 110956
24Antineoplastic Agents, PhytogenicPhase 4, Phase 2, Phase 1, Early Phase 15602
25Antineoplastic Agents, AlkylatingPhase 4, Phase 2, Phase 1, Early Phase 14603
26Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 110729
27Folic Acid AntagonistsPhase 4, Phase 2, Phase 12257
28Etoposide phosphatePhase 4, Phase 2, Phase 1, Early Phase 11269
29Antimitotic AgentsPhase 4, Phase 2, Phase 15657
30Anti-Bacterial AgentsPhase 4, Phase 2, Phase 111226
31Nucleic Acid Synthesis InhibitorsPhase 4, Phase 24962
32AntimetabolitesPhase 4, Phase 2, Phase 112054
33Antibiotics, AntitubercularPhase 4, Phase 2, Phase 17180
34Antimetabolites, AntineoplasticPhase 4, Phase 2, Phase 17361
35Dermatologic AgentsPhase 4, Phase 2, Phase 15806
36Isophosphamide mustardPhase 4, Phase 1400
37Vitamin B9NutraceuticalPhase 4, Phase 2, Phase 14392
38FolateNutraceuticalPhase 4, Phase 2, Phase 14392
39
rituximabapprovedPhase 1, Phase 21692174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
40
Sorafenibapproved, investigationalPhase 2700284461-73-0216239, 406563
Synonyms:
284461-73-0
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 439006
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY-43-9006
BAY-54-9085
BAY43-9006
BRD-K23984367-001-01-8
Bio-0100
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
 
D08524
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
NSC-724772
NSC747971
Nexavar
STK627350
Sorafenib
Sorafenib (INN)
Sorafenib [INN]
Sorafenib tosylate
Sorafenibum
UNII-9ZOQ3TZI87
ZINC01493878
nchembio.117-comp17
sorafenib
sorafenibum
41
alemtuzumabapproved, investigationalPhase 2310216503-57-0
Synonyms:
Campath
 
MabCampath
alemtuzumab
42
Cyclosporineapproved, investigational, vet_approvedPhase 2, Phase 192279217-60-0, 59865-13-35284373, 6435893
Synonyms:
1c5f
1cyn
30024_FLUKA
30024_SIGMA
59865-13-3
79217-60-0
AC1L1EQW
AC1NQXJE
AC1NR4C4
AC1NUQK3
AC1NUZNC
AC1O5KOG
AC1Q2UDG
Ambap59865-13-3
Ambotz59865-13-3
Antibiotic S 7481F1
BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA
BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA
BPBio1_000496
BRD-A64290322-001-01-6
BRD-A69815203-001-04-3
BRD-K13533483-001-03-0
BSPBio_000450
BSPBio_001596
BSPBio_003186
C 3662
C05086
C1832_SIGMA
C3662_SIGMA
C62H111N11O12
CB-01-09 MMX
CHEBI:106343
CHEBI:328305
CHEBI:4031
CHEMBL160
CHEMBL386389
CHEMBL532318
CID2909
CID5280754
CID5284373
CID5458585
CID5497195
CID6435893
CSA
CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A))
CYCLOSPORIN A, USP
Ciclosporin
Ciclosporin (JP15)
Ciclosporina
Ciclosporine
Ciclosporinum
Cipol N
Cipol-N
Consupren
Consupren S
CsA
CsA & IFN.alpha.
CyA
Cyclokat
Cyclosporin
Cyclosporin A
Cyclosporin A & IFN.alpha.
Cyclosporin A Implant
Cyclosporin A, Tolypocladium inflatum
Cyclosporine (USP)
Cyclosporine A
Cyclosporine [USAN]
D00184
DE-076
DivK1c_000871
EU-0100242
Equoral
GNF-Pf-2808
Gengraf
Gengraf (TN)
HMS1569G12
HMS1791P18
HMS1921L20
HMS1989P18
HMS2089A09
HMS2092F06
HMS502L13
Helv Chim Acta 60: 1568 (1977)
 
I06-0379
I06-0966
IDI1_000871
KBio1_000871
KBio2_000780
KBio2_003348
KBio2_005916
KBio3_002686
KBioGR_001898
KBioSS_000780
LMPK14000003
LS-257
LS-58836
Lopac0_000242
MLS000028376
MLS001333756
MLS002153454
MLS002207033
Mitogard
Modusik-A
MolPort-000-760-988
MolPort-005-934-008
MolPort-006-705-994
NCGC00093704-01
NCGC00093704-02
NCGC00093704-03
NCGC00093704-04
NCGC00093704-05
NCGC00093704-06
NCGC00093704-07
NCGC00093704-08
NCGC00164258-01
NCGC00164258-02
NINDS_000871
NSC290193
Neoplanta
Neoral
Neoral (TN)
NeuroSTAT
Nova-22007
OL 27-400
OL-27400
OLO-400
Papilock
Prestwick2_000435
Prestwick3_000435
Prestwick_731
Pulminiq
Ramihyphin A
Restasis
Restasis (TN)
S-Neoral
S1514_Selleck
SDZ-OXL 400
SMR000058578
SPBio_001467
SPECTRUM1502202
ST-603
Sandimmun
Sandimmun Neoral
Sandimmune
Sandimmune (TN)
Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine
Sang-2000
Sang-35
SangCyA
Sangcya
Sigmasporin
Sigmasporin Microoral
Spectrum2_001484
Spectrum3_001593
Spectrum4_001279
Spectrum5_001628
Spectrum_000300
TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)
Vekacia
Zyclorin
cyclophorine
cyclosporin A
cyclosporine
from Tolypocladium inflatum (Trichoderma polysporin)
nchembio.184-comp6
nchembio.301-comp5
nchembio.342-comp1
43
Dasatinibapproved, investigationalPhase 1, Phase 2285302962-49-83062316
Synonyms:
(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
1N1
2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide
302962-49-8
AC1MI3ET
AC1Q2P0C
AmbotzLS-1203
Anhydrous dasatinib
BCB03_000715
BMS 354825
BMS dasatinib
BMS-354825
BMS-354825, Sprycel, BMS354825, Dasatinib
BMS354825
C488369
CHEBI:49375
CHEMBL1421
CID3062316
D03658
DB01254
Dasatinib
Dasatinib (USAN)
Dasatinib (anh.)
Dasatinib [USAN]
Dasatinib anhydrous
Dasatinib, BMS 354825
Dasatinibum
EC-000.2122
 
EN002710
FT-0084503
I14-1972
Kinome_3650
LS-186641
LS-187028
LS-187773
MolPort-003-846-143
N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE
N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide
N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate
N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
NCGC00181129-01
NSC-732517
NSC732517
S1021_Selleck
SPRYCEL (TN)
Sprycel
Spyrcel
UNII-X78UG0A0RN
anh. dasatinib
dasatinib
dasatinib (anhydrous)
dasatinibum
nchembio.117-comp11
nchembio.162-comp4
nchembio.332-comp1
44
Busulfanapproved, investigationalPhase 2, Early Phase 154555-98-12478
Synonyms:
1, 4-Dimethanesulfonoxybutane
1, 4-Dimethylsulfonoxybutane
1, {4-Bis[methanesulfonoxy]butane}
1,4-BUTANEDIOL DIMETHANESULFONATE
1,4-Bis(methanesulfonoxy)butane
1,4-Bis(methanesulfonyloxy)butane
1,4-Bis[methanesulfonoxy]butane
1,4-Butanedi yl dimethanesulfonate
1,4-Butanediol dimethanesulfonate
1,4-Butanediol dimethanesulphonate
1,4-Butanediol dimethylsulfonate
1,4-Butanediol, dimethanesulfonate
1,4-Butanediol, dimethanesulphonate
1,4-Butanediyl dimethanesulfonate
1,4-Di(methylsulfonoxy)butane
1,4-Dimesyloxybutane
1,4-Dimethane sulfonyl oxybutane
1,4-Dimethanesulfonoxybutane
1,4-Dimethanesulfonoxylbutane
1,4-Dimethanesulfonyloxybutane
1,4-Dimethanesulphonyloxybutane
1,4-Dimethylsulfonoxybutane
1,4-Dimethylsulfonyloxybutane
2041 C. B
2041 C. B.
2041 C.B
2041 C.B.
4-((Methylsulfonyl)oxy)butyl methanesulfonate
4-methylsulfonyloxybutyl methanesulfonate
55-98-1
AC-198
AC1L1DRQ
AC1Q4GRQ
AI3-25012
AKOS003614975
AN 33501
Ambap55-98-1
B1022
B2635_FLUKA
B2635_SIGMA
BRN 1791786
BSPBio_001920
BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE)
Bisulfex
Busilvex
Busulfan
Busulfan (JP15/USP/INN)
Busulfan GlaxoSmithKline Brand
Busulfan Orphan Brand
Busulfan Wellcome
Busulfan Wellcome Brand
Busulfan [INN:JAN]
Busulfano
Busulfano [INN-Spanish]
Busulfanum
Busulfanum [INN-Latin]
Busulfex
Busulphan
Busulphane
Butanedioldimethanesulfonate
Buzulfan
C.B. 2041
C6H14O6S2
CB 2041
CCRIS 418
CHEBI:28901
CHEMBL820
CID2478
CPD000058613
Citosulfan
D002066
D00248
DB01008
DivK1c_000847
EINECS 200-250-2
FT-0083567
G.T. 41
GT 2041
GT 41
Glaxo Wellcome Brand of Busulfan
GlaxoSmithKline Brand of Busulfan
Glyzophrol
HMS1920I07
HMS2091O09
HMS502K09
 
HSDB 7605
I09-1371
IDI1_000847
InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
KBio1_000847
KBio2_000512
KBio2_003080
KBio2_005648
KBio3_001420
KBioGR_000698
KBioSS_000512
LS-1358
Leucosulfan
MLS001076666
MYLERAN (TN)
Mablin
Methanesulfonic
Methanesulfonic acid, tetram ethylene ester
Methanesulfonic acid, tetramethylene ester
Mielevcin
Mielosan
Mielucin
Milecitan
Mileran
Misulban
Mitosan
Mitostan
MolPort-001-783-406
Myeleukon
Myeloleukon
Myelosan
Myelosanum
Mylecytan
Myleran
Myleran Tablets
Myleran tablets
Myleran, Busulfex, Busulfan
Mylerlan
NCGC00090905-01
NCGC00090905-02
NCGC00090905-03
NCGC00090905-04
NCGC00090905-05
NCGC00090905-06
NCGC00090905-07
NCI-C01592
NCI60_041640
NCIMech_000192
NINDS_000847
NSC 750
NSC-750
NSC-750sulphabutin
NSC750
Orphan Brand of Busulfan
Prestwick_989
S1692_Selleck
SAM002554887
SMR000058613
SPBio_000253
SPECTRUM1500152
ST50825921
Spectrum2_000067
Spectrum3_000320
Spectrum4_000259
Spectrum5_000928
Spectrum_000092
Sulfabutin
Sulfabutin (VAN)
Sulphabutin
Tetramethylene Dimethane Sulfonate
Tetramethylene bis(methanesulfonate)
Tetramethylene bis[methanesulfonate]
Tetramethylene dimethane sulfonate
Tetramethylene {bis[methanesulfonate]}
Tetramethylenester Kyseliny Methansulfonove
Tetramethylenester kyseliny methansulfonove
Tetramethylenester kyseliny methansulfonove [Czech]
UNII-G1LN9045DK
WLN: WS1&O4OSW1
Wellcome Brand of Busulfan
Wellcome, Busulfan
X 149
acid, tetramethylene ester
alkylating agent: crosslinks guanine residues
busulfan
butane-1,4-diyl dimethanesulfonate
n-Butane-1,3-di(methylsulfonate)
45
Mycophenolate mofetilapproved, investigationalPhase 2, Phase 1952128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
46
Prednisoloneapproved, vet_approvedPhase 2119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
47
Tacrolimusapproved, investigationalPhase 21102104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
48
HydroxocobalaminapprovedPhase 1, Phase 225813422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
Hydro Cobex
 
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin anhydrous
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobalaminum anhydrous
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
49
Methylprednisoloneapproved, vet_approvedPhase 2119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
50
GemcitabineapprovedPhase 2, Phase 1201895058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2

Interventional clinical trials:

(show top 50)    (show all 73)
idNameStatusNCT IDPhase
1Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of NetherlandsCompletedNCT00731536Phase 4
2A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)RecruitingNCT01804166Phase 4
3CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell LymphomaRecruitingNCT01746992Phase 4
4Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin LymphomaUnknown statusNCT01336933Phase 2
5Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ LymphomasUnknown statusNCT01805037Phase 1, Phase 2
6Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell LymphomaCompletedNCT00901147Phase 2
7Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin LymphomaCompletedNCT01466881Phase 2
8Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's LymphomaCompletedNCT00131937Phase 2
9Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid TumorsCompletedNCT01326702Phase 1, Phase 2
10Study of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaCompletedNCT01258998Phase 2
11High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCompletedNCT01177371Phase 2
12Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid MalignanciesCompletedNCT00072514Phase 2
13Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00118352Phase 2
14Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesCompletedNCT01427881Phase 2
15Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerCompletedNCT00049504Phase 2
16Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesCompletedNCT00481871Phase 1, Phase 2
17Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell LymphomaRecruitingNCT03075553Phase 2
18A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)RecruitingNCT02588651Phase 2
19Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's LymphomaRecruitingNCT02561273Phase 1, Phase 2
20Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell LymphomaRecruitingNCT03113500Phase 2
21Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell LymphomaRecruitingNCT02232516Phase 2
22CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and LymphomaRecruitingNCT02742727Phase 1, Phase 2
23Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesRecruitingNCT01839916Phase 2
24Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesRecruitingNCT01760655Phase 2
25Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin LymphomaRecruitingNCT01609816Phase 1, Phase 2
26Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesRecruitingNCT01643603Phase 1, Phase 2
27CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II StudyRecruitingNCT01719835Phase 2
28Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin LymphomaActive, not recruitingNCT00918333Phase 1, Phase 2
29Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaActive, not recruitingNCT01261247Phase 2
30Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaActive, not recruitingNCT01075321Phase 1, Phase 2
31Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerActive, not recruitingNCT00006251Phase 1, Phase 2
32Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerActive, not recruitingNCT00089011Phase 2
33Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesActive, not recruitingNCT01529827Phase 2
34Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT00078858Phase 1, Phase 2
35Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesActive, not recruitingNCT00040846Phase 2
36Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal CancerTerminatedNCT01769222Phase 1, Phase 2
37Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplantTerminatedNCT01419795Phase 2
38Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's LymphomaTerminatedNCT00810576Phase 2
39Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWithdrawnNCT01652014Phase 2
40Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell LymphomaCompletedNCT01129180Phase 1
41Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
42Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
43MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaCompletedNCT01748721Phase 1
44Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01658319Phase 1
45Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
46Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaCompletedNCT01273090Phase 1
47CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaRecruitingNCT02168140Phase 1
48Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell LymphomasActive, not recruitingNCT01445535Phase 1
49Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaActive, not recruitingNCT01567709Phase 1
50AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaActive, not recruitingNCT01129193Phase 1

Search NIH Clinical Center for Hepatosplenic T-Cell Lymphoma

Genetic Tests for Hepatosplenic T-Cell Lymphoma

About this section

Anatomical Context for Hepatosplenic T-Cell Lymphoma

About this section

MalaCards organs/tissues related to Hepatosplenic T-Cell Lymphoma:

36
Spleen, T cells, B cells, Thyroid, Endothelial, Myeloid, Bone

Publications for Hepatosplenic T-Cell Lymphoma

About this section

Articles related to Hepatosplenic T-Cell Lymphoma:

(show top 50)    (show all 101)
idTitleAuthorsYear
1
Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-I+ inhibitor therapy and literature review. (28038706)
2017
2
Distinguishing Between Hepatosplenic T-cell Lymphoma and I^I' T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. (27755009)
2017
3
Hepatosplenic T-cell lymphoma: an acute leukemia presentation. (27158719)
2016
4
Four hepatosplenic T-cell lymphoma cases of Japanese patients. (26870659)
2016
5
Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. (26997444)
2016
6
Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia. (26708981)
2016
7
Cutaneous presentation of hepatosplenic T-cell lymphoma-a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma. (27562705)
2016
8
Hepatosplenic T-cell lymphoma in a young immunocompetent man. (27033291)
2016
9
Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis. (27516526)
2016
10
Hepatosplenic T Cell Lymphoma in an Immunocompetent Female Diagnosed using Flow Cytometry: A Rare Clinical Entity. (27656456)
2016
11
Hepatosplenic T-cell lymphoma with blastoid morphology in a patient with Crohn disease. (27811192)
2016
12
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. (26872013)
2016
13
Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy. (28058028)
2016
14
Gastroenterology: Hepatosplenic T cell lymphoma associated with schistosomiasis. (26211690)
2015
15
Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma. (26047388)
2015
16
Childhood Hepatosplenic T-cell Lymphoma with Skin Involvement. (26061932)
2015
17
Hepatosplenic T-cell lymphoma with coexistent hepatitis B infection: a rare clinicopathologic entity. (26481866)
2015
18
Hepatosplenic T-cell lymphoma mimicking bone marrow metastasis. (26788568)
2015
19
Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms. (26317456)
2015
20
Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated Disease. (27099586)
2015
21
Hepatosplenic T-cell lymphoma with aberrant expression of serum I^-HCG: a case report. (26108251)
2015
22
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis. (24761381)
2014
23
Frequent STAT5B mutations in I^I' hepatosplenic T-cell lymphomas. (24947020)
2014
24
Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma? (24524924)
2014
25
Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report. (24621139)
2014
26
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. (25057852)
2014
27
Hepatosplenic T-cell lymphoma: a rare cause of hepatosplenomegaly. (25012882)
2014
28
Purpura of the face and neck: an atypical clinical presentation revealing a hepatosplenic T cell lymphoma. (24707248)
2014
29
Hepatosplenic T-cell lymphoma. (25221804)
2014
30
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party. (25234166)
2014
31
De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls. (24978925)
2014
32
Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma. (25065703)
2014
33
Hepatosplenic T-cell lymphoma: A case series. (25450840)
2014
34
Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks? (24621284)
2014
35
Hepatosplenic T cell lymphoma. (25332524)
2014
36
Hepatosplenic T cell lymphoma: a rare case report. (25332523)
2014
37
CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma. (23800602)
2013
38
Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma. (23826928)
2013
39
Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant. (23598914)
2013
40
Histopathological, immunophenotypic and clinical particularities and evolution of a case of hepatosplenic T-cell lymphoma in transformation to leukemia. (24399013)
2013
41
Hepatosplenic T-cell lymphoma: is cure possible? (23598915)
2013
42
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. (23107915)
2013
43
Hepatosplenic T-cell lymphoma. (24033076)
2013
44
Hepatosplenic T-cell lymphoma appearing in the peripheral blood. (24137640)
2013
45
F-18 Fluorodeoxyglucose non-avid hepatosplenic T cell lymphoma: a diagnostic pitfall. (21584668)
2012
46
The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. (21823196)
2012
47
Differential diagnosis of CD4-/CD8- I^I' T-cell large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma. (22338065)
2012
48
Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India. (21916832)
2012
49
F-18 flourodeoxyglucose positron emission tomography/computed tomography findings in a case of hepatosplenic T-cell lymphoma. (22531524)
2012
50
Hematologic features of hepatosplenic T-cell lymphoma. (22261460)
2012

Variations for Hepatosplenic T-Cell Lymphoma

About this section

Expression for genes affiliated with Hepatosplenic T-Cell Lymphoma

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Hepatosplenic T-Cell Lymphoma patients vs. healthy controls: 35 (show all 400)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1TMEM178Atransmembrane protein 178ASpleen+9.710.000
2LPAR3lysophosphatidic acid receptor 3Spleen+8.910.000
3SOX2SRY (sex determining region Y)-box 2Spleen+8.600.000
4MLC1megalencephalic leukoencephalopathy with subcortical cysts 1Spleen+7.680.001
5CLEC3BC-type lectin domain family 3, member BSpleen-7.160.001
6KIR2DS1killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1Spleen+7.160.000
7HLA-DQA1major histocompatibility complex, class II, DQ alpha 1Spleen-7.010.023
8KIR3DL1killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1Spleen+6.950.000
9KIR3DS1killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1Spleen+6.850.001
10ADAMTS17ADAM metallopeptidase with thrombospondin type 1 motif, 17Spleen+6.830.000
11KIR3DL3killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3Spleen+6.660.000
12KIR2DL3killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3Spleen+6.630.001
13MARCOmacrophage receptor with collagenous structureSpleen+6.610.009
14KIR2DS3killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3Spleen+6.340.001
15CXCL13chemokine (C-X-C motif) ligand 13Spleen-6.260.004
16OLFML2Aolfactomedin-like 2ASpleen-6.250.015
17KIR2DL2killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2Spleen+6.210.002
18KIR2DS2killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2Spleen+6.140.000
19KIR2DS4killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4Spleen+6.130.001
20GREB1growth regulation by estrogen in breast cancer 1Spleen+6.090.001
21KIR2DL1killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1Spleen+6.020.002
22LOC100505501uncharacterized LOC100505501Spleen+5.960.000
23MAATS1MYCBP-associated, testis expressed 1Spleen-5.930.000
24TRGV5T cell receptor gamma variable 5Spleen+5.900.000
25CRHBPcorticotropin releasing hormone binding proteinSpleen-5.890.000
26KLRC3killer cell lectin-like receptor subfamily C, member 3Spleen+5.870.000
27SMIM24small integral membrane protein 24Spleen+5.850.000
28CCM2Lcerebral cavernous malformation 2-likeSpleen-5.830.005
29RUNDC3BRUN domain containing 3BSpleen+5.820.000
30HLA-DQB1major histocompatibility complex, class II, DQ beta 1Spleen+5.800.000
31PCDH7protocadherin 7Spleen-5.780.010
32APLNRapelin receptorSpleen-5.760.000
33KIR2DL5Akiller cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5ASpleen+5.730.001
34KIR2DS5killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5Spleen+5.690.001
35GIPC2GIPC PDZ domain containing family, member 2Spleen-5.690.000
36GTSF1gametocyte specific factor 1Spleen+5.620.001
37GPM6Aglycoprotein M6ASpleen-5.620.000
38IGFBP3insulin-like growth factor binding protein 3Spleen-5.610.004
39BMP7bone morphogenetic protein 7Spleen+5.590.000
40PDE2Aphosphodiesterase 2A, cGMP-stimulatedSpleen-5.580.002
41KIF14kinesin family member 14Spleen+5.550.000
42HYAL1hyaluronoglucosaminidase 1Spleen-5.510.006
43GPR82G protein-coupled receptor 82Spleen+5.490.000
44DNASE1L3deoxyribonuclease I-like 3Spleen-5.440.003
45USP44ubiquitin specific peptidase 44Spleen+5.440.000
46CD96CD96 moleculeSpleen+5.420.001
47AKAP5A kinase (PRKA) anchor protein 5Spleen+5.410.000
48RNASE1ribonuclease, RNase A family, 1 (pancreatic)Spleen-5.400.008
49PLVAPplasmalemma vesicle associated proteinSpleen-5.380.001
50NEK2NIMA-related kinase 2Spleen+5.350.000
51KCNAB1potassium channel, voltage gated subfamily A regulatory beta subunit 1Spleen-5.290.000
52HCAR3hydroxycarboxylic acid receptor 3Spleen-5.290.006
53CHODLchondrolectinSpleen-5.280.001
54GBA3glucosidase, beta, acid 3 (gene/pseudogene)Spleen-5.250.000
55NCAM1neural cell adhesion molecule 1Spleen+5.190.003
56PBKPDZ binding kinaseSpleen+5.160.000
57DLGAP5discs, large (Drosophila) homolog-associated protein 5Spleen+5.130.001
58HSPB8heat shock 22kDa protein 8Spleen-5.110.002
59PITPNM3PITPNM family member 3Spleen-5.090.010
60CHMP4Ccharged multivesicular body protein 4CSpleen-5.090.000
61PTX3pentraxin 3, longSpleen-5.070.012
62KIF20Akinesin family member 20ASpleen+5.050.000
63FAM110Bfamily with sequence similarity 110, member BSpleen-5.040.005
64SDPRserum deprivation responseSpleen-5.030.012
65BIRC5baculoviral IAP repeat containing 5Spleen+5.020.000
66LIMCH1LIM and calponin homology domains 1Spleen-4.990.006
67CENPFcentromere protein F, 350/400kDaSpleen+4.980.000
68TOP2Atopoisomerase (DNA) II alphaSpleen+4.980.000
69KIAA0101KIAA0101Spleen+4.980.000
70ZNF521zinc finger protein 521Spleen-4.960.004
71KIF2Ckinesin family member 2CSpleen+4.950.000
72ASPMabnormal spindle microtubule assemblySpleen+4.940.001
73TSPAN12tetraspanin 12Spleen-4.930.006
74TEKTEK tyrosine kinase, endothelialSpleen-4.920.021
75SLCO4C1solute carrier organic anion transporter family, member 4C1Spleen+4.910.001
76BUB1BUB1 mitotic checkpoint serine/threonine kinaseSpleen+4.890.001
77SEPP1selenoprotein P, plasma, 1Spleen-4.890.000
78CD79ACD79a molecule, immunoglobulin-associated alphaSpleen-4.890.039
79ST6GALNAC1ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1Spleen-4.850.000
80ADAMDEC1ADAM-like, decysin 1Spleen-4.850.008
81UHRF1ubiquitin-like with PHD and ring finger domains 1Spleen+4.840.000
82FLRT3fibronectin leucine rich transmembrane protein 3Spleen+4.820.012
83PCDH17protocadherin 17Spleen-4.820.041
84BLNKB-cell linkerSpleen-4.810.036
85SERPINA5serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5Spleen-4.800.004
86CDKN3cyclin-dependent kinase inhibitor 3Spleen+4.800.001
87DSPdesmoplakinSpleen-4.790.000
88STAB2stabilin 2Spleen-4.740.022
89TPX2TPX2, microtubule-associatedSpleen+4.730.000
90KCNQ5potassium channel, voltage gated KQT-like subfamily Q, member 5Spleen+4.730.000
91CFIcomplement factor ISpleen-4.720.025
92CENPAcentromere protein ASpleen+4.700.001
93PDGFDplatelet derived growth factor DSpleen+4.690.000
94TK1thymidine kinase 1, solubleSpleen+4.670.000
95CENPEcentromere protein E, 312kDaSpleen+4.660.000
96FCRLBFc receptor-like BSpleen+4.660.001
97HOMER3homer scaffolding protein 3Spleen-4.650.022
98KIF18Bkinesin family member 18BSpleen+4.650.001
99NKX2-3NK2 homeobox 3Spleen-4.640.026
100GDPD2glycerophosphodiester phosphodiesterase domain containing 2Spleen-4.640.000
101DEPDC1DEP domain containing 1Spleen+4.630.000
102TARPTCR gamma alternate reading frame proteinSpleen+4.630.000
103PTPRBprotein tyrosine phosphatase, receptor type, BSpleen-4.610.013
104KLF4Kruppel-like factor 4 (gut)Spleen-4.600.011
105TMSB15Athymosin beta 15aSpleen+4.600.002
106AXLAXL receptor tyrosine kinaseSpleen-4.600.001
107SIRPGsignal-regulatory protein gammaSpleen+4.590.000
108MIB2mindbomb E3 ubiquitin protein ligase 2Spleen+4.590.000
109CNTN1contactin 1Spleen-4.590.000
110E2F7E2F transcription factor 7Spleen+4.590.000
111CYYR1cysteine/tyrosine-rich 1Spleen-4.580.002
112KAZNkazrin, periplakin interacting proteinSpleen-4.570.003
113EPHA7EPH receptor A7Spleen-4.560.000
114GINS2GINS complex subunit 2 (Psf2 homolog)Spleen+4.560.000
115DEPDC1BDEP domain containing 1BSpleen+4.550.000
116NUF2NUF2, NDC80 kinetochore complex componentSpleen+4.550.000
117ADIRFadipogenesis regulatory factorSpleen-4.550.008
118CDH11cadherin 11, type 2, OB-cadherin (osteoblast)Spleen-4.550.015
119FAM83Dfamily with sequence similarity 83, member DSpleen+4.540.000
120TYMSthymidylate synthetaseSpleen+4.530.000
121FOXM1forkhead box M1Spleen+4.530.000
122C1orf115chromosome 1 open reading frame 115Spleen-4.520.007
123TCL1AT-cell leukemia/lymphoma 1ASpleen-4.520.024
124UBE2Cubiquitin-conjugating enzyme E2CSpleen+4.520.000
125THBDthrombomodulinSpleen-4.510.022
126S100BS100 calcium binding protein BSpleen+4.500.022
127MKI67marker of proliferation Ki-67Spleen+4.500.000
128ARHGEF40Rho guanine nucleotide exchange factor (GEF) 40Spleen-4.490.000
129GPR183G protein-coupled receptor 183Spleen-4.480.012
130KIF15kinesin family member 15Spleen+4.480.001
131CD163L1CD163 molecule-like 1Spleen-4.470.001
132ABCB1ATP-binding cassette, sub-family B (MDR/TAP), member 1Spleen+4.470.000
133NOS3nitric oxide synthase 3 (endothelial cell)Spleen-4.470.021
134OIP5Opa interacting protein 5Spleen+4.460.000
135SLC16A9solute carrier family 16, member 9Spleen-4.460.010
136CEP55centrosomal protein 55kDaSpleen+4.460.000
137ROBO4roundabout guidance receptor 4Spleen-4.460.007
138CXCL12chemokine (C-X-C motif) ligand 12Spleen-4.440.011
139LGR4leucine-rich repeat containing G protein-coupled receptor 4Spleen-4.440.000
140THRBthyroid hormone receptor, betaSpleen-4.430.000
141MYCT1myc target 1Spleen-4.430.010
142E2F8E2F transcription factor 8Spleen+4.420.000
143TMEM200Atransmembrane protein 200ASpleen+4.420.002
144AIF1Lallograft inflammatory factor 1-likeSpleen-4.420.029
145PSD3pleckstrin and Sec7 domain containing 3Spleen-4.420.005
146NDRG2NDRG family member 2Spleen-4.410.006
147CCNB2cyclin B2Spleen+4.400.001
148EPHX1epoxide hydrolase 1, microsomal (xenobiotic)Spleen-4.390.019
149NDRG4NDRG family member 4Spleen-4.390.000
150MCM10minichromosome maintenance 10 replication initiation factorSpleen+4.390.000
151TOXthymocyte selection-associated high mobility group boxSpleen+4.360.001
152APOEapolipoprotein ESpleen-4.360.016
153HJURPHolliday junction recognition proteinSpleen+4.360.000
154CHSY3chondroitin sulfate synthase 3Spleen+4.360.000
155CCL24chemokine (C-C motif) ligand 24Spleen-4.360.001
156METMET proto-oncogene, receptor tyrosine kinaseSpleen-4.350.001
157CDCA7cell division cycle associated 7Spleen+4.340.001
158VWFvon Willebrand factorSpleen-4.340.021
159ARHGAP28Rho GTPase activating protein 28Spleen-4.340.014
160PRC1protein regulator of cytokinesis 1Spleen+4.340.000
161IGHDimmunoglobulin heavy constant deltaSpleen-4.340.012
162MGPmatrix Gla proteinSpleen-4.340.010
163CHST9carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9Spleen-4.340.000
164RTN1reticulon 1Spleen-4.330.035
165SLC14A1solute carrier family 14 (urea transporter), member 1 (Kidd blood group)Spleen+4.330.006
166FAM179Afamily with sequence similarity 179, member ASpleen+4.320.001
167MYRIPmyosin VIIA and Rab interacting proteinSpleen-4.320.004
168EFHD1EF-hand domain family, member D1Spleen-4.320.023
169TSPAN7tetraspanin 7Spleen-4.310.017
170CPB1carboxypeptidase B1 (tissue)Spleen-4.310.000
171FCRLAFc receptor-like ASpleen-4.290.027
172FPR3formyl peptide receptor 3Spleen-4.290.019
173KIR2DL4killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4Spleen+4.290.009
174CCNA2cyclin A2Spleen+4.280.000
175SHANK3SH3 and multiple ankyrin repeat domains 3Spleen-4.270.011
176CD22CD22 moleculeSpleen-4.270.023
177FXYD6FXYD domain containing ion transport regulator 6Spleen-4.270.026
178EZH2enhancer of zeste 2 polycomb repressive complex 2 subunitSpleen+4.270.000
179ANLNanillin actin binding proteinSpleen+4.260.000
180NUDT11nudix (nucleoside diphosphate linked moiety X)-type motif 11Spleen+4.250.010
181NUSAP1nucleolar and spindle associated protein 1Spleen+4.250.000
182AURKBaurora kinase BSpleen+4.240.000
183CAV1caveolin 1, caveolae protein, 22kDaSpleen-4.220.017
184BUB1BBUB1 mitotic checkpoint serine/threonine kinase BSpleen+4.210.000
185FASLGFas ligand (TNF superfamily, member 6)Spleen+4.210.000
186PLEKHG1pleckstrin homology domain containing, family G (with RhoGef domain) member 1Spleen-4.200.005
187CDC20cell division cycle 20Spleen+4.200.003
188INSRinsulin receptorSpleen-4.200.020
189C8orf4chromosome 8 open reading frame 4Spleen-4.200.015
190CNTN3contactin 3 (plasmacytoma associated)Spleen-4.200.000
191CD247CD247 moleculeSpleen+4.190.000
192EPPK1epiplakin 1Spleen-4.190.001
193PRSS21protease, serine, 21 (testisin)Spleen+4.190.000
194NOGnogginSpleen+4.180.033
195CDCA2cell division cycle associated 2Spleen+4.180.000
196GTSE1G-2 and S-phase expressed 1Spleen+4.180.001
197SH2D2ASH2 domain containing 2ASpleen+4.170.000
198FLJ35700uncharacterized protein FLJ35700Spleen-4.170.008
199RRM2ribonucleotide reductase M2Spleen+4.160.001
200C2orf40chromosome 2 open reading frame 40Spleen-4.150.032
201MELKmaternal embryonic leucine zipper kinaseSpleen+4.150.000
202CASC5cancer susceptibility candidate 5Spleen+4.150.000
203PAX5paired box 5Spleen-4.140.044
204LILRB5leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5Spleen-4.140.017
205CCNB1cyclin B1Spleen+4.130.001
206SLC4A4solute carrier family 4 (sodium bicarbonate cotransporter), member 4Spleen+4.130.009
207ADGRF5adhesion G protein-coupled receptor F5Spleen-4.130.046
208KLHL14kelch-like family member 14Spleen-4.120.038
209VPREB3pre-B lymphocyte 3Spleen-4.120.018
210MESTmesoderm specific transcriptSpleen-4.110.006
211ERGv-ets avian erythroblastosis virus E26 oncogene homologSpleen-4.110.009
212KLRC4killer cell lectin-like receptor subfamily C, member 4Spleen+4.100.028
213NCAPGnon-SMC condensin I complex, subunit GSpleen+4.100.000
214NR4A2nuclear receptor subfamily 4, group A, member 2Spleen+4.100.045
215CCNE2cyclin E2Spleen+4.100.000
216TM4SF18transmembrane 4 L six family member 18Spleen-4.090.035
217BRIP1BRCA1 interacting protein C-terminal helicase 1Spleen+4.090.000
218IGF1insulin-like growth factor 1 (somatomedin C)Spleen-4.080.001
219FCRL2Fc receptor-like 2Spleen-4.080.013
220HMMRhyaluronan-mediated motility receptor (RHAMM)Spleen+4.070.001
221TMEM150Ctransmembrane protein 150CSpleen-4.070.007
222ITGA1integrin, alpha 1Spleen-4.070.048
223NELL2neural EGFL like 2Spleen+4.060.006
224NTN4netrin 4Spleen-4.060.016
225CAV2caveolin 2Spleen-4.060.014
226CKAP2Lcytoskeleton associated protein 2-likeSpleen+4.050.000
227CDK1cyclin-dependent kinase 1Spleen+4.050.000
228LY86lymphocyte antigen 86Spleen-4.050.007
229CDT1chromatin licensing and DNA replication factor 1Spleen+4.050.000
230RPS6KA2ribosomal protein S6 kinase, 90kDa, polypeptide 2Spleen-4.050.003
231C3orf70chromosome 3 open reading frame 70Spleen-4.040.001
232SPAG5sperm associated antigen 5Spleen+4.030.000
233APBA2amyloid beta (A4) precursor protein-binding, family A, member 2Spleen+4.030.001
234TRIM2tripartite motif containing 2Spleen-4.030.010
235ERAP2endoplasmic reticulum aminopeptidase 2Spleen-4.020.000
236NMUneuromedin USpleen+4.020.022
237KLRD1killer cell lectin-like receptor subfamily D, member 1Spleen+4.020.000
238TTKTTK protein kinaseSpleen+4.010.000
239RAMP1receptor (G protein-coupled) activity modifying protein 1Spleen+4.010.012
240FCRL1Fc receptor-like 1Spleen-4.010.006
241ETS2v-ets avian erythroblastosis virus E26 oncogene homolog 2Spleen-4.000.007
242CRTAMcytotoxic and regulatory T cell moleculeSpleen+4.000.000
243LIFRleukemia inhibitory factor receptor alphaSpleen-4.000.049
244TREM1triggering receptor expressed on myeloid cells 1Spleen-3.990.000
245MOB3BMOB kinase activator 3BSpleen-3.990.027
246LRP4low density lipoprotein receptor-related protein 4Spleen-3.990.000
247STOX2storkhead box 2Spleen-3.990.001
248CHEK1checkpoint kinase 1Spleen+3.990.000
249ACKR1atypical chemokine receptor 1 (Duffy blood group)Spleen-3.980.015
250FABP3fatty acid binding protein 3, muscle and heartSpleen-3.980.015
251MMRN2multimerin 2Spleen-3.980.005
252AGTR1angiotensin II receptor, type 1Spleen-3.970.013
253GNLYgranulysinSpleen-3.970.038
254EBF1early B-cell factor 1Spleen-3.960.011
255SPOCK1sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1Spleen-3.950.008
256MCM4minichromosome maintenance complex component 4Spleen+3.940.000
257TMTC1transmembrane and tetratricopeptide repeat containing 1Spleen-3.940.039
258KIF11kinesin family member 11Spleen+3.940.000
259LGALS2lectin, galactoside-binding, soluble, 2Spleen-3.930.004
260PLK2polo-like kinase 2Spleen-3.920.012
261TRDT cell receptor delta locusSpleen+3.920.024
262IGSF21immunoglobin superfamily, member 21Spleen-3.920.000
263S1PR5sphingosine-1-phosphate receptor 5Spleen+3.920.006
264PCSK6proprotein convertase subtilisin/kexin type 6Spleen-3.910.005
265SEMA3Dsema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3DSpleen-3.910.007
266PHGDHphosphoglycerate dehydrogenaseSpleen+3.910.008
267GAPTGRB2-binding adaptor protein, transmembraneSpleen-3.900.026
268SPIBSpi-B transcription factor (Spi-1/PU.1 related)Spleen-3.900.016
269CDC6cell division cycle 6Spleen+3.900.001
270UBE2Tubiquitin-conjugating enzyme E2TSpleen+3.890.000
271RMI2RecQ mediated genome instability 2Spleen+3.880.000
272ENTPD3ectonucleoside triphosphate diphosphohydrolase 3Spleen-3.880.000
273BLKBLK proto-oncogene, Src family tyrosine kinaseSpleen-3.870.004
274FGD5FYVE, RhoGEF and PH domain containing 5Spleen-3.870.004
275ELOVL6ELOVL fatty acid elongase 6Spleen+3.860.004
276NCAPHnon-SMC condensin I complex, subunit HSpleen+3.860.000
277HOMER1homer scaffolding protein 1Spleen+3.850.002
278ITGADintegrin, alpha DSpleen+3.850.001
279ARHGAP29Rho GTPase activating protein 29Spleen-3.840.023
280MPPED2metallophosphoesterase domain containing 2Spleen-3.840.004
281ADGRL4adhesion G protein-coupled receptor L4Spleen-3.830.050
282CCL19chemokine (C-C motif) ligand 19Spleen-3.830.037
283NAV3neuron navigator 3Spleen-3.830.001
284NRP1neuropilin 1Spleen-3.830.034
285HLA-DOBmajor histocompatibility complex, class II, DO betaSpleen-3.820.034
286PROX1prospero homeobox 1Spleen-3.820.003
287CDCA8cell division cycle associated 8Spleen+3.820.000
288RORBRAR-related orphan receptor BSpleen+3.810.004
289CDCA5cell division cycle associated 5Spleen+3.810.000
290CES1carboxylesterase 1Spleen-3.810.017
291ASB9ankyrin repeat and SOCS box containing 9Spleen-3.810.000
292MYH11myosin, heavy chain 11, smooth muscleSpleen-3.790.027
293SPC25SPC25, NDC80 kinetochore complex componentSpleen+3.790.000
294PLPP3phospholipid phosphatase 3Spleen-3.790.024
295JAKMIP2janus kinase and microtubule interacting protein 2Spleen+3.790.003
296ATAD2ATPase family, AAA domain containing 2Spleen+3.790.000
297MRAP2melanocortin 2 receptor accessory protein 2Spleen-3.770.002
298ITM2Aintegral membrane protein 2ASpleen+3.770.007
299MND1meiotic nuclear divisions 1Spleen+3.760.002
300AMIGO2adhesion molecule with Ig-like domain 2Spleen-3.760.019
301BCHEbutyrylcholinesteraseSpleen-3.760.003
302SHESrc homology 2 domain containing ESpleen-3.760.012
303CD37CD37 moleculeSpleen-3.760.042
304JUNjun proto-oncogeneSpleen-3.760.013
305GNG7guanine nucleotide binding protein (G protein), gamma 7Spleen-3.750.000
306ID1inhibitor of DNA binding 1, dominant negative helix-loop-helix proteinSpleen-3.740.006
307EXO1exonuclease 1Spleen+3.740.000
308GNG12guanine nucleotide binding protein (G protein), gamma 12Spleen-3.730.042
309FAM129Cfamily with sequence similarity 129, member CSpleen-3.730.012
310PTGDRprostaglandin D2 receptor (DP)Spleen+3.720.000
311AQP3aquaporin 3 (Gill blood group)Spleen-3.720.005
312GINS1GINS complex subunit 1 (Psf1 homolog)Spleen+3.720.000
313IGHA1immunoglobulin heavy constant alpha 1Spleen-3.720.005
314POLE2polymerase (DNA directed), epsilon 2, accessory subunitSpleen+3.720.000
315CDH2cadherin 2, type 1, N-cadherin (neuronal)Spleen-3.710.016
316NPR3natriuretic peptide receptor 3Spleen-3.710.000
317GALNT15polypeptide N-acetylgalactosaminyltransferase 15Spleen-3.710.000
318TRIP13thyroid hormone receptor interactor 13Spleen+3.700.001
319DUSP1dual specificity phosphatase 1Spleen-3.700.002
320GLI3GLI family zinc finger 3Spleen+3.680.004
321AQP9aquaporin 9Spleen-3.680.049
322PLEKHA5pleckstrin homology domain containing, family A member 5Spleen+3.670.001
323NRN1neuritin 1Spleen-3.670.004
324PNOCprepronociceptinSpleen-3.670.008
325CAMTA1calmodulin binding transcription activator 1Spleen-3.670.008
326SNCAIPsynuclein, alpha interacting proteinSpleen-3.670.026
327OLFM1olfactomedin 1Spleen-3.660.000
328AFF3AF4/FMR2 family, member 3Spleen-3.660.008
329TMEM100transmembrane protein 100Spleen-3.660.038
330SPC24SPC24, NDC80 kinetochore complex componentSpleen+3.660.004
331HELLShelicase, lymphoid-specificSpleen+3.650.000
332BCL11AB-cell CLL/lymphoma 11A (zinc finger protein)Spleen-3.650.036
333ITGA6integrin, alpha 6Spleen-3.640.011
334ZWINTZW10 interacting kinetochore proteinSpleen+3.640.000
335IL13RA1interleukin 13 receptor, alpha 1Spleen-3.640.028
336NDNnecdin, melanoma antigen (MAGE) family memberSpleen-3.630.032
337BTNL9butyrophilin-like 9Spleen-3.630.020
338KIF18Akinesin family member 18ASpleen+3.630.000
339AS3MTarsenite methyltransferaseSpleen-3.630.033
340EGFL7EGF-like-domain, multiple 7Spleen-3.620.002
341EOMESeomesoderminSpleen+3.620.001
342FAM107Afamily with sequence similarity 107, member ASpleen-3.620.020
343TMEFF1transmembrane protein with EGF-like and two follistatin-like domains 1Spleen+3.610.013
344FCER2Fc fragment of IgE, low affinity II, receptor for (CD23)Spleen-3.610.013
345BHLHE41basic helix-loop-helix family, member e41Spleen-3.610.031
346CDCA3cell division cycle associated 3Spleen+3.590.001
347CDKN1Ccyclin-dependent kinase inhibitor 1C (p57, Kip2)Spleen-3.590.009
348PRDM16PR domain containing 16Spleen+3.580.000
349C18orf54chromosome 18 open reading frame 54Spleen+3.570.002
350ANGPTL2angiopoietin-like 2Spleen-3.570.034
351DOCK5dedicator of cytokinesis 5Spleen-3.570.001
352LRIG3leucine-rich repeats and immunoglobulin-like domains 3Spleen-3.560.002
353ARHGAP24Rho GTPase activating protein 24Spleen-3.550.000
354AURKAaurora kinase ASpleen+3.550.001
355AREGamphiregulinSpleen+3.550.032
356RAD51RAD51 recombinaseSpleen+3.550.000
357IL7Rinterleukin 7 receptorSpleen-3.540.026
358FAM9Cfamily with sequence similarity 9, member CSpleen-3.540.008
359FAM150Bfamily with sequence similarity 150, member BSpleen-3.530.008
360C5AR1complement component 5a receptor 1Spleen-3.520.048
361CD8BCD8b moleculeSpleen+3.520.039
362NRXN3neurexin 3Spleen-3.520.005
363TCF19transcription factor 19Spleen+3.520.000
364CDRT4CMT1A duplicated region transcript 4Spleen+3.520.019
365CD3GCD3g molecule, gamma (CD3-TCR complex)Spleen+3.520.002
366PROK2prokineticin 2Spleen-3.510.006
367CSF3Rcolony stimulating factor 3 receptor (granulocyte)Spleen-3.510.001
368TLR10toll-like receptor 10Spleen-3.510.017
369GMPRguanosine monophosphate reductaseSpleen+3.500.013
370MMP16matrix metallopeptidase 16 (membrane-inserted)Spleen+3.500.001
371DIAPH3diaphanous-related formin 3Spleen+3.500.000
372ASF1Banti-silencing function 1B histone chaperoneSpleen+3.490.001
373FANCIFanconi anemia, complementation group ISpleen+3.470.001
374GGHgamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)Spleen+3.460.002
375MCM2minichromosome maintenance complex component 2Spleen+3.460.000
376KIFC1kinesin family member C1Spleen+3.450.000
377SH3RF3SH3 domain containing ring finger 3Spleen+3.450.004
378RACGAP1Rac GTPase activating protein 1Spleen+3.450.000
379PPP1R9Aprotein phosphatase 1, regulatory subunit 9ASpleen+3.430.003
380CENPNcentromere protein NSpleen+3.430.001
381DNA2DNA replication helicase/nuclease 2Spleen+3.420.000
382CENPWcentromere protein WSpleen+3.410.001
383CENPUcentromere protein USpleen+3.390.000
384WDHD1WD repeat and HMG-box DNA binding protein 1Spleen+3.390.001
385AKAP12A kinase (PRKA) anchor protein 12Spleen+3.370.003
386DSCC1DNA replication and sister chromatid cohesion 1Spleen+3.360.001
387ESPL1extra spindle pole bodies like 1, separaseSpleen+3.360.000
388MCM7minichromosome maintenance complex component 7Spleen+3.360.001
389ENPP5ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)Spleen+3.350.000
390MYH10myosin, heavy chain 10, non-muscleSpleen+3.340.009
391LARP6La ribonucleoprotein domain family, member 6Spleen+3.340.025
392CENPKcentromere protein KSpleen+3.310.000
393POLQpolymerase (DNA directed), thetaSpleen+3.290.000
394TRDV3T cell receptor delta variable 3Spleen+3.290.029
395SLC25A15solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15Spleen+3.280.002
396PLCB1phospholipase C, beta 1 (phosphoinositide-specific)Spleen+3.280.001
397THEMISthymocyte selection associatedSpleen+3.280.000
398PLEKHG4pleckstrin homology domain containing, family G (with RhoGef domain) member 4Spleen+3.270.001
399CMC1C-x(9)-C motif containing 1Spleen+3.260.000
400DPY19L2P2DPY19L2 pseudogene 2Spleen+3.250.002

Search GEO for disease gene expression data for Hepatosplenic T-Cell Lymphoma.

Pathways for genes affiliated with Hepatosplenic T-Cell Lymphoma

About this section

Pathways related to Hepatosplenic T-Cell Lymphoma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.1CD7, GZMB

GO Terms for genes affiliated with Hepatosplenic T-Cell Lymphoma

About this section

Biological processes related to Hepatosplenic T-Cell Lymphoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1T cell activationGO:00421109.4CD7, DPP4

Sources for Hepatosplenic T-Cell Lymphoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet